Peregrine Pharma (PPHM) Reports In-Line Q3 Loss of 13c/Share

March 9, 2012 4:02 PM EST Send to a Friend
Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM) reported Q3 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $3.28 million versus the consensus estimate of $2.12 million.

For earnings history and earnings-related data on Peregrine Pharmaceuticals, Inc. (PPHM) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings

Add Your Comment